Russia’s draft budget cuts cancer-project line as ministry points to insurance funding

Russia’s draft 2027 federal budget would allocate 3.9 billion roubles to its separate cancer project, Kommersant reported on 8 October, down from 44.9 billion roubles in the current 2026 allocation. The Health Ministry says the change reflects a shift in how cancer care is financed, leaving a central question for patients: whether other budgets will maintain access to treatment.

The government has submitted the 2027–2029 budget package to the State Duma. Its figures are proposals, so neither the project allocation nor the ministry’s account of replacement funding establishes what will ultimately be spent or what services patients will receive.

How much the federal cancer-project line would fall

Kommersant reported that the draft provides about 3.9 billion roubles for the project in 2027. It compared that amount with the 144.9 billion roubles initially allocated for 2026, a difference of about 141 billion. The comparison changes when the current allocation is used: by 1 September, the 2026 project line had already been reduced to 44.9 billion roubles, according to the consolidated budget schedule cited by the newspaper.

The ministry put planned spending through the federal project at 22.5 billion roubles over three years: 3.9 billion in 2027, 5.8 billion in 2028 and 12.8 billion in 2029. It said the remaining project money would be used exclusively to equip regions with specialised treatment equipment. Those figures describe one named programme, rather than the entire system that pays for cancer care.

What the Health Ministry says will replace the funding

The ministry said compulsory-insurance transfers to regions are planned to rise 9.6% in 2027, to 4.3769 trillion roubles. That would be 64.4 billion roubles above the amount previously planned for 2026. It also projected a 9.6% rise, to 378.9 billion roubles, in insurance funding for federal clinics providing specialised and high-technology care. These are broad funding streams; the supplied figures do not isolate how much of either increase will pay for oncology services.

According to the ministry, higher insurance-contribution receipts and accumulated balances in the Federal Compulsory Medical Insurance Fund underpin the planned funding. It said the draft contains no separate additional federal transfer to that fund for cancer care. Kommersant reported that the fund’s draft 2027 budget forecasts 5.038 trillion roubles in revenue and 5.206 trillion in spending, with the planned deficit covered by carried-over balances.

Why the overall health budget does not settle the question

The government’s budget announcement says total healthcare spending in 2027 would exceed 7 trillion roubles: 1.8 trillion from the federal budget and 5.2 trillion through the Federal Compulsory Medical Insurance Fund. It says health spending would increase compared with 2026 and describes health, social commitments, defence and security as priorities. Those totals do not specify how much will be available for the cancer services at issue.

Another accounting change remains unresolved. Kommersant reported that the approved 2026–2028 budget separately provided about 140 billion roubles a year for cancer care under clinical recommendations, while the new draft contains no equivalent separate line. The available figures do not show precisely where all that funding would appear in the proposed financing structure.

Patient questions and the budget’s wider priorities

The patient organisation Movement Against Cancer wrote to Prime Minister Mikhail Mishustin seeking an explanation of the planned reduction, according to Kommersant. The ministry says increased insurance funding should support access for insured patients, including those needing oncology services, and expand availability. Whether that expectation is met cannot be determined from the draft allocations alone.

Euronews reported that the draft assigns 17.1 trillion roubles to defence in 2027, about 35% of federal expenditure. The government’s budget announcement puts total federal spending at 48.8 trillion roubles but does not itself give that defence figure. The defence comparison places the cancer-project proposal within the wider budget; it does not establish that a specific amount was transferred from cancer care to defence.

The State Duma must consider the proposed budget. For patients, the unresolved issue is how the smaller project line, compulsory-insurance funding and regional budgets will work together in practice. The published figures and ministry statements describe planned financing, but do not yet demonstrate whether access, coverage or service levels will be maintained.